Omada Health, Inc. (OMDA)
NASDAQ: OMDA · Real-Time Price · USD
11.87
-0.63 (-5.04%)
At close: Nov 20, 2026, 4:00 PM EST
11.81
-0.06 (-0.51%)
After-hours: Nov 20, 2026, 7:30 PM EST
Omada Health Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Omada Health stock has a consensus rating of "Buy" and an average price target of $26.5. The average 1-year stock price forecast is 123.25% higher than the current stock price, while the lowest is $19 (+60.07%) and the highest is $35 (+194.86%).
Price Target: $26.5 (+123.25%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Omada Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Hold | 2 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 12 | 12 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Buy Maintains $30 → $25 | Buy | Maintains | $30 → $25 | +110.61% | Nov 16, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Reiterates $30 | Buy | Reiterates | $30 | +152.74% | Nov 9, 2026 |
| Canaccord Genuity | Canaccord Genuity | Buy Reiterates $28 | Buy | Reiterates | $28 | +135.89% | Nov 6, 2026 |
| BMO Capital | BMO Capital | Buy Maintains $24 | Buy | Maintains | $24 | +102.19% | Nov 6, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $22 → $19 | Hold | Maintains | $22 → $19 | +60.07% | Nov 6, 2026 |
Financial Forecast
Revenue This Year
345.15M
from 260.21M
Increased by 32.64%
Revenue Next Year
411.81M
from 345.15M
Increased by 19.31%
EPS This Year
0.57
from 0.15
Increased by 268.42%
EPS Next Year
0.69
from 0.57
Increased by 21.07%
EPS and Forward PE are based on non-GAAP adjusted numbers.